Veuger, Stan A.; Clemens, Jeffrey - American Enterprise Institute - 2015
We describe the broad range of uncertainties faced by the developers of medicalÂÂ technologies. Empirically, we estimate the asset market incidence of the realization ÂÂ of two such of uncertainties experienced by the biotechnology firmÂÂ Myriad Genetics, Inc.